Table 1.
Age | Men | Women | Total |
---|---|---|---|
Number/Total Number (%)a | |||
50–59 y | 82/4038 (2.0) | 59/4335 (1.4) | 141/8373 (1.7) |
60–69 y | 105/1858 (3.7) | 73/3155 (2.3) | 178/6019 (3.0) |
70–79 y | 104/2864 (5.6) | 101/2650 (3.8) | 205/4508 (4.6) |
≥ 80 y | 59/709 (8.3) | 111/1854 (6.0) | 170/2563 (6.6) |
Total | 350/9469 (3.7)b | 344/11,994 (2.9) b | 694/21,463 (3.2) b,c |
The percentage was calculated as the number of patients with MGUS divided by the number who were tested.
Prevalence was age-adjusted to the 2000 US total population as follows: men, 4.0% (95% confidence interval, 3.5 to 4.4); women, 2.7% (95% confidence interval, 2.4 to 3.0); and total, 3.2% (95% confidence interval, 3.0 to 3.5).
Prevalence was age- and sex-adjusted to the 2000 US total population.
From Kyle RA et al. N Engl J Med. 2006.[9] Copyright © 2006 by the Massachusetts Medical Society. All rights reserved.